Biologists find a way to lower tumour risk in stem cell therapies
Friday, July 9, 2010 - 05:14
in Health & Medicine
One of the characteristics of embryonic stem cells is their ability to form unusual tumours called teratomas. These tumours, which contain a mixture of cells from a variety of tissues and organs of the body, are typically benign. But they present a major obstacle to the development of human embryonic stem cell therapies that seek to treat a variety of human ailments such as Parkinson's, diabetes, genetic blood disorders and spinal cord injuries...